Events Search and Views Navigation
June 2021
2021 AAHP Summit: Developing HPUS Guidelines for FDA Compliance, Part 2
Does your company experience a gap between 21 CFR cGMP requirements and the pragmatic realities of implementation for homeopathic drug products? AAHP, in partnership with the Homeopathic Pharmacopoeia Convention of the United States (HPCUS), has identified five technical gaps that are challenges for both industry and FDA inspectors. In a continuation of this industrywide, multi-year effort, the 2021 Summit will present:
• Concept Paper: Process Validation for Preparation of Hahnemannian Liquids
• White Paper: Control of Active Pharmaceutical Ingredients
• Views on these pharmaceutical quality issues and necessary compliance considerations by Richard Lostritto, PhD, Associate Director for Science, Office of Policy for Pharmaceutical Quality at FDA’s CDER.
September 2020
AAHP Virtual Summit: Developing HPUS Guidelines for FDA Compliance
Join the alliance of homeopathic manufacturers, pharmacists, and other qualified parties in the homeopathic community for this powerful one-day investment featuring in-depth presentations by experts specifically in the homeopathic industry. AAHP will assemble the highest quality information on key topics in a format that is responsive to attendees needs and regulators expectations. Discussions will affect the future, providing retailers, practitioners and consumers better, safer, reliable products for their wellbeing.
Find out more »